Takeda's Precision & Translational Medicine (PTM) team is seeking to deliver transformational cures to patients through innovative translational research and development. The PTM Strategic Innovations (PSI) team aims to drive advancements in clinical-decision making by integrating cutting-edge technologies into clinical workflows, specifically exploring the development and validation of AI/ML models for digital pathology applications and their expanded use in clinical pipelines.
Requirements
- Demonstrated experience or coursework in machine learning, and data analysis, and/or image analysis (traditional or ML-based techniques)
- A strong foundation in biology, chemistry, biochemistry, histology, immunology, or a related scientific field
- Knowledge and interest in pathology and its application in the healthcare industry
Responsibilities
- Collaborate with our internal and external teams to interpret machine learning model outputs related to disease patterns in clinical pathology images
- Contribute to the development of innovative quantitative biomarkers related to the tumor microenvironment to help predict patient response to potential immunotherapies
- Analyze and interpret complex data sets to extract actionable insights that will inform strategic decisions, and effectively communicate these findings to the team and stakeholders.
- Assist in the design and execution of experiments to validate and optimize machine learning models, ensuring their efficacy and reliability in the field of digital pathology
- Develop multi-modal ML models using digital pathology foundational model embeddings and related, orthogonal data
- Evaluate new technologies (e.g. virtual staining) for their feasibility and impact on drug development pipelines
Other
- This position will be Hybrid out of the Cambridge, MA location
- Must be pursuing a Doctoral Degree in Computer Science, Bioinformatics, Pathology, or a related field
- Exceptional communication and teamwork abilities
- Excellent quantitative, analytical, and problem-solving skills
- Graduate, PhD, MD student with completion of a minimum of one year of university studies
- Must be authorized to work in the U.S. on a permanent basis without requiring sponsorship
- Must be currently enrolled in a degree program graduating December 2026 or later
